Literature DB >> 30039783

Waterborne Infections in Reunion Island, 2010-2017.

Nicolas Allou1, Aurélien Soubeyrand1, Nicolas Traversier2, Romain Persichini1, Caroline Brulliard1, Dorothée Valance1, Olivier Martinet1, Sandrine Picot3, Olivier Belmonte2, Jérôme Allyn1.   

Abstract

Gram-negative bacilli Vibrio spp., Aeromonas spp., and Shewanella spp. are a major cause of severe waterborne infection. The aim of this study was to assess the clinical and microbiological characteristics and prognosis of patients hospitalized in Reunion Island for a waterborne infection. This retrospective study was conducted in the two university hospitals of Reunion Island between January 2010 and March 2017. Patients diagnosed with a Vibrio, Aeromonas, or Shewanella infection were evaluated. Over the study period, 112 aquatic strains were isolated at Reunion Island: Aeromonas spp. were found in 91 patients (81.3%), Shewanella spp. in 13 patients (11.6%), and Vibrio spp. in eight patients (7.2%). The in-hospital mortality rate was 11.6%. The main sites of infection were skin and soft tissue (44.6%) and the abdomen (19.6%). Infections were polymicrobial in 70 cases (62.5%). The most commonly prescribed empiric antibiotic regimen was amoxicillin-clavulanate (34.8%). Eighty-four percent of the aquatic strains were resistant to amoxicillin-clavulanate and more than > 95% were susceptible to third or fourth generation cephalosporins and fluoroquinolones. After multivariate analysis, the only independent risk factor of in-hospital mortality was the presence of sepsis (P < 0.0001). In Reunion Island, the most commonly isolated aquatic microorganisms were Aeromonas spp. Sepsis caused by aquatic microorganisms was frequent (> 50%) and associated with higher in-hospital mortality. This study suggests that empiric antibiotic regimens in patients with sepsis or septic shock caused by suspected aquatic microorganisms (tropical climate, skin lesion exposed to seawater…) should include broad-spectrum antibiotics (third or fourth generation cephalosporins).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30039783      PMCID: PMC6169186          DOI: 10.4269/ajtmh.17-0981

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  EUCAST technical note on Amphotericin B.

Authors:  C Lass-Flörl; M C Arendrup; J-L Rodriguez-Tudela; M Cuenca-Estrella; P Donnelly; W Hope
Journal:  Clin Microbiol Infect       Date:  2011-10-19       Impact factor: 8.067

2.  Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.

Authors:  B Lamy; F Laurent; A Kodjo; F Roger; E Jumas-Bilak; H Marchandin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-27       Impact factor: 3.267

3.  Bacteremia and empyema caused by Shewanella algae in a trauma patient.

Authors:  Susan Jacob-Kokura; Claire Y Chan; Lewis Kaplan
Journal:  Ann Pharmacother       Date:  2014-01-06       Impact factor: 3.154

4.  Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: a 10-yr retrospective study.

Authors:  Shiuan-Chih Chen; Khee-Siang Chan; Wai-Nang Chao; Po-Hui Wang; Ding-Bang Lin; Kwo-Chang Ueng; Sheng-Hung Kuo; Chun-Chieh Chen; Meng-Chih Lee
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

5.  Clinical manifestation and prognostic factors of non-cholerae Vibrio infections.

Authors:  C C Hou; C C Lai; W L Liu; C M Chao; Y H Chiu; P R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-22       Impact factor: 3.267

6.  Occurrence of Staphylococcus and enteropathogens in soft cheese commercialized in the city of Rio de Janeiro, Brazil.

Authors:  V S Araújo; V A Pagliares; M L P Queiroz; A C Freitas-Almeida
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

7.  Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group.

Authors:  W C Levine; P M Griffin
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

8.  Clinical implications of species identification in monomicrobial Aeromonas bacteremia.

Authors:  Chi-Jung Wu; Po-Lin Chen; Po-Ren Hsueh; Ming-Chung Chang; Pei-Jane Tsai; Hsin-I Shih; Hsuan-Chen Wang; Pei-Hsin Chou; Wen-Chien Ko
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

9.  Species Distribution and Prevalence of Putative Virulence Factors in Mesophilic Aeromonas spp. Isolated from Fresh Retail Sushi.

Authors:  Sunniva Hoel; Olav Vadstein; Anita N Jakobsen
Journal:  Front Microbiol       Date:  2017-05-24       Impact factor: 5.640

10.  Aeromonas Diversity and Antimicrobial Susceptibility in Freshwater-An Attempt to Set Generic Epidemiological Cut-Off Values.

Authors:  Sandrine Baron; Sophie A Granier; Emeline Larvor; Eric Jouy; Maelan Cineux; Amandine Wilhelm; Benoit Gassilloud; Sophie Le Bouquin; Isabelle Kempf; Claire Chauvin
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

View more
  3 in total

Review 1.  Shewanella spp. Bloodstream Infections in Queensland, Australia.

Authors:  Kevin B Laupland; Adam G Stewart; Felicity Edwards; David L Paterson; Sonali Coulter; Claire Heney; Narelle George; Patrick Harris
Journal:  Emerg Infect Dis       Date:  2022-04       Impact factor: 6.883

2.  Community-acquired Pseudomonas aeruginosa Osteomyelitis Caused by an Injury from a Dishwasher.

Authors:  Yoshiyuki Matsuki; Sayaka Tanabe; Takayuki Yokozawa; Sayori Li; Toshimi Oda
Journal:  Intern Med       Date:  2022-03-12       Impact factor: 1.282

3.  Skin and soft-tissue infections associated with Aeromonas species in French Guiana: an 11-year retrospective study.

Authors:  M Devos; V Sainte-Rose; H Kallel; C Mayence; H Ouedraogo; F Djossou; M Demar; P Couppié; R Blaizot
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-14       Impact factor: 6.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.